Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Capital Work in Progress

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Capital Work in Progress ₹4,496 Cr₹2,938 Cr₹2,429 Cr₹1,622 Cr₹1,342 Cr

What is the latest Capital Work in Progress ratio of AUROBINDO PHARMA ?

The latest Capital Work in Progress ratio of AUROBINDO PHARMA is ₹4,496 Cr based on Mar2023 Consolidated results.
Year Capital Work in Progress
Mar2023₹4,496 Cr
Mar2022₹2,938 Cr
Mar2021₹2,429 Cr
Mar2020₹1,622 Cr
Mar2019₹1,342 Cr

How is Capital Work in Progress of AUROBINDO PHARMA Trending?

Years Capital Work in Progress % Change
Mar2023 ₹4,496 Cr
53.07
Mar2022 ₹2,938 Cr
20.94
Mar2021 ₹2,429 Cr
49.77
Mar2020 ₹1,622 Cr
20.85
Mar2019 ₹1,342 Cr -

Compare Capital Work in Progress of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹67,536.7 Cr 1.9% 3.6% 87.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

1.9%

3.6%

87.2%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses